LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: Maternal Serum Screening Markers and Adverse Outcome: A New Perspective.

    Krantz, David / Hallahan, Terrence / Janik, David / Carmichael, Jonathan

    Journal of clinical medicine

    2014  Volume 3, Issue 3, Page(s) 693–712

    Abstract: ... a re-evaluation of the benefit of serum markers in the identification of adverse outcomes. Analysis ... with adverse pregnancy outcome. More recently, the development of potential treatments for these adverse ... There have been a number of studies evaluating the association of aneuploidy serum markers ...

    Abstract There have been a number of studies evaluating the association of aneuploidy serum markers with adverse pregnancy outcome. More recently, the development of potential treatments for these adverse outcomes as well as the introduction of cell-free fetal DNA (cffDNA) screening for aneuploidy necessitates a re-evaluation of the benefit of serum markers in the identification of adverse outcomes. Analysis of the literature indicates that the serum markers tend to perform better in identifying pregnancies at risk for the more severe but less frequent form of individual pregnancy complications rather than the more frequent but milder forms of the condition. As a result, studies which evaluate the association of biomarkers with a broad definition of a given condition may underestimate the ability of such markers to identify pregnancies that are destined to develop the more severe form of the condition. Consideration of general population screening using cffDNA solely must be weighed against the fact that traditional screening using serum markers enables detection of severe pregnancy complications, not detectable with cffDNA, of which many may be amenable to treatment options.
    Language English
    Publishing date 2014-07-03
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm3030693
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Maternal Serum Screening Markers and Adverse Outcome

    David Krantz / Terrence Hallahan / David Janik / Jonathan Carmichael

    Journal of Clinical Medicine, Vol 3, Iss 3, Pp 693-

    A New Perspective

    2014  Volume 712

    Abstract: ... a re-evaluation of the benefit of serum markers in the identification of adverse outcomes. Analysis ... with adverse pregnancy outcome. More recently, the development of potential treatments for these adverse ... There have been a number of studies evaluating the association of aneuploidy serum markers ...

    Abstract There have been a number of studies evaluating the association of aneuploidy serum markers with adverse pregnancy outcome. More recently, the development of potential treatments for these adverse outcomes as well as the introduction of cell-free fetal DNA (cffDNA) screening for aneuploidy necessitates a re-evaluation of the benefit of serum markers in the identification of adverse outcomes. Analysis of the literature indicates that the serum markers tend to perform better in identifying pregnancies at risk for the more severe but less frequent form of individual pregnancy complications rather than the more frequent but milder forms of the condition. As a result, studies which evaluate the association of biomarkers with a broad definition of a given condition may underestimate the ability of such markers to identify pregnancies that are destined to develop the more severe form of the condition. Consideration of general population screening using cffDNA solely must be weighed against the fact that traditional screening using serum markers enables detection of severe pregnancy complications, not detectable with cffDNA, of which many may be amenable to treatment options.
    Keywords aneuploidy screening ; preeclampsia ; IUGR ; preterm birth ; fetal loss ; placenta accreta ; open neural tube defects ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2014-07-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top